7 drugmakers to watch during Q3 earnings

7 drugmakers to watch during Q3 earnings

Source: 
Biopharma Dive
snippet: 

Major themes that defined the pharma industry in the first half of 2018 carried into the third quarter. Drug pricing remained the hottest of hot-button issues, biosimilars are still threatening blockbuster brands, and restructurings revived some investor optimism — albeit at the expense of many jobs.